Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading ->
Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading ->
The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading ->
People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading ->
BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading ->
The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading ->
Ibadan, Nigeria. Several Nigerian states were unable to carry out preventative yellow fever campaigns late last year because of the COVID-19 pandemic, leaving thousands of people at risk of developing the disease as the country now faces a new winter yellow fever outbreak, Health Policy Watch learned. In early November, Nigeria’s Center for Disease Control […] Continue reading ->
As European COVID-19 vaccine campaigns got underway with celebratory first jabs into the arms of citizens in half a dozen countries, some seasoned observers were still wondering if the pace of vaccine roll-outs will move fast enough to outpace the continuing high levels of infection and fatality – now being fuelled by a new mutant […] Continue reading ->
The redacted WHO report on Italy’s pandemic response, “An Unprecedented Challenge” contained a brief timeline of events in the early days of the SARS-CoV-2 outbreak in China, which a number of WHO officials sought to amend or suppress even before the entire report was recalled. In fact, the so-called “China box” on the outbreak’s early […] Continue reading ->
Cape Town – As South Africa records over 930,000 COVID-19 cases and its scientists race to understand whether a new variant is driving the country’s second wave of infections, countries across the African continent are reporting an increase in cases. But there is widespread anecdotal evidence that many African countries are massively under-reporting their COVID-19 […] Continue reading ->